WallStreetZenWallStreetZen

NYSE: HLN
Haleon PLC Earnings Dates, Reports, Calls

OverviewEarnings
RevenueDividendOwnership
Haleon earnings were $2.3B for the trailing 12 months ending Dec 31, 2025, with 27.3% growth year over year. The latest HLN earnings report on Dec 31, 2025 announced Q4 2025 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, HLN reported annual earnings of $2.3B, with 25% growth. The next HLN earnings date is Apr 29, 2026.

HLN past earnings growth

How has HLN's earnings growth performed historically?

Company
27.34%
Industry
55.14%
Market
87.41%
HLN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HLN's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
HLN's earnings growth is accelerating... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

HLN earnings history

Current Revenue
$14.9B
Current Earnings
$2.3B
Current Profit Margin
15.1%

HLN Return on Equity

Current Company
10.2%
Current Industry
13.4%
Current Market
28.9%
HLN's Return on Equity (10.2%)... subscribe to Premium to read more.
High Return on Equity Performance

HLN Return on Assets

Current Company
5%
Current Industry
5.3%
HLN is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when HLN announces earnings.

HLN Return on Capital Employed

Current Company
8.67%
Current Industry
11.7%
HLN has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HLN vs Pharmaceutical Stocks

TickerEBITDAEarningsY/Y EarningsEPS
HLN$3.57B$2.25B+8.15%$0.50
ZTS$4.07B$2.67B+11.88%$6.03
TEVA$3.17B$1.41B+34.13%$1.23
TAK$8.59B$737.40M-16.20%$0.24
VTRS-$395.40M-$3.51BN/A-$3.00
View Top Pharmaceutical Stocks

HLN earnings dates

Next earnings date
Apr 29, 2026

Haleon Earnings Reports & History FAQ

What were Haleon's earnings last quarter?

On HLN's earnings call on Invalid Date, Haleon (NYSE: HLN) reported Q4 2025 earnings per share (EPS) of N/A, up N/A year over year. Total HLN earnings for the quarter were N/A. In the same quarter last year, Haleon's earnings per share (EPS) was N/A.

If you're new to stock investing, here's how to buy Haleon stock.

When does Haleon report earnings?

The next HLN earnings date is Invalid Date. Add HLN to your watchlist to be reminded of Haleon's next earnings date.

Is Haleon profitable or losing money?

As of the last Haleon earnings report, Haleon is currently profitable. Haleon's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $2.25 billion, a 24.98% increase year over year.

What was HLN's earnings growth in the past year?

As of Haleon's earnings date in Invalid Date, Haleon's earnings has grown 27.34% year over year. This is 27.8 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry earnings growth rate of 55.14%. HLN earnings in the past year totalled $2.25 billion.

What are Haleon's earnings expectations?

The current EPS estimate for Haleon's earnings report in Invalid Date is $0.12.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.